Literature DB >> 21095025

Prevalence of hyperuricemia and its association with antihypertensive treatment in hypertensive patients in Taiwan.

Chung-Sheng Lin1, Wen-Ling Lee, Yi-Jen Hung, Du-Yi Lee, Kuei-Feng Chen, Wen-Che Chi, Shin-Chieh Chang.   

Abstract

BACKGROUND: Hyperuricemia is thought to be associated with an increased risk of hypertension, impaired renal function and cardiovascular disease. Our aim is to study the prevalence of hyperuricemia and its association with antihypertensive treatment in Taiwanese hypertensive subjects.
METHODS: We recruited 2145 hypertensive subjects from 19 hospitals in four areas of Taiwan. We assessed the prevalence of hyperuricemia and determined the independent risk factors for raised serum uric acid level by multiple logistic regression analyses.
RESULTS: Compared to the general population, hypertensive subjects in Taiwan had a higher prevalence (mean 35% in males, 43% in females) of hyperuricemia; this prevalence being 1.5- and 1.7-fold higher in males and females respectively. Uric acid levels; gout and prevalence of hyperuricemia were found to be highest in the younger age group (20-39 years) and no regional differences were noted. The most important risk factors for hyperuricemia were impaired renal function and diuretic use. Serum uric acid values correlated significantly with four quintiles of serum creatinine (p<0.0001) independent of diuretic use. Diuretic users had a significantly elevated serum uric acid and serum creatinine values than non-users. Among the patients given diuretics, hyperuricemia occurred in 44% of those given thiazides, in 56% of those given loop diuretics, and in 57% of those given aldosterone receptor blockers.
CONCLUSIONS: Diuretic usage and renal function status have a strong impact on the prevalence of hyperuricemia in Taiwanese hypertensive subjects. It is still unclear, however, whether diuretics induce renal failure through elevating serum uric acid levels. Copyright Â
© 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21095025     DOI: 10.1016/j.ijcard.2010.10.033

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  12 in total

1.  [Relationship between hyperuricemia and adverse events in patients aged 40 years or older receiving rheumatic aortic valve replacement].

Authors:  Ying Wu; Zu-Hui Ke; Ying-Jie Huang; Jie-Leng Huang; Dan-Qing Yu; Xue-Biao Wei; Xiao-Lan Chen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-07-20

2.  Outpatient Hypertension Control and Prescribing Habits for Hypertension in Taiwan.

Authors:  Chung-Sheng Lin; Yung-Hua Chu; Yi-Jen Hung; Du-Yi Lee; Cheng-Yun Chen
Journal:  Acta Cardiol Sin       Date:  2013-11       Impact factor: 2.672

3.  Association of Serum Uric Acid with Cardiovascular Disease in Taiwanese Patients with Primary Hypertension.

Authors:  Tsung-Yuan Yang; Chih-Yuan Fang; Jung-Sheng Chen; Helen L Po; Li-Ping Chou; Chih-Yeng Chiang; Kwo-Chang Ueng
Journal:  Acta Cardiol Sin       Date:  2015-01       Impact factor: 2.672

4.  Prevalence of Adverse Events in Children With Congenital Hyperinsulinism Treated With Diazoxide.

Authors:  Adriana Herrera; Mary Ellen Vajravelu; Stephanie Givler; Lauren Mitteer; Catherine M Avitabile; Katherine Lord; Diva D De León
Journal:  J Clin Endocrinol Metab       Date:  2018-12-01       Impact factor: 5.958

5.  Effects of xanthine oxidase inhibitors on renal function and blood pressure in hypertensive patients with hyperuricemia.

Authors:  Kentaro Kohagura; Takeshi Tana; Akira Higa; Masanobu Yamazato; Akio Ishida; Kazufumi Nagahama; Atsushi Sakima; Kunitoshi Iseki; Yusuke Ohya
Journal:  Hypertens Res       Date:  2016-04-14       Impact factor: 3.872

6.  Incidence of and risk factors for nephrolithiasis in patients with gout and the general population, a cohort study.

Authors:  A J Landgren; L T H Jacobsson; U Lindström; T Z S Sandström; P Drivelegka; L Björkman; E Fjellstedt; M Dehlin
Journal:  Arthritis Res Ther       Date:  2017-07-24       Impact factor: 5.156

7.  Hyper-Uricemia and Gouty Access in the Adult Population of the Southeast of Gabon: Biochemical Aspects.

Authors:  Guy Roger Ndong Atome; Rick-Leonid Ngoua Meye Misso; Cédric Sima Obiang; Richard Onanga; Dieudonné Nkogue Mba
Journal:  Diseases       Date:  2018-03-08

Review 8.  Inflammation in Renal Diseases: New and Old Players.

Authors:  Vinicius Andrade-Oliveira; Orestes Foresto-Neto; Ingrid Kazue Mizuno Watanabe; Roberto Zatz; Niels Olsen Saraiva Câmara
Journal:  Front Pharmacol       Date:  2019-10-08       Impact factor: 5.810

9.  Prevalence of hyperuricemia and its related risk factors in healthy adults from Northern and Northeastern Chinese provinces.

Authors:  Ling Qiu; Xin-qi Cheng; Jie Wu; Jun-ting Liu; Tao Xu; Hai-tao Ding; Yan-hong Liu; Zeng-mei Ge; Ya-jing Wang; Hui-juan Han; Jing Liu; Guang-jin Zhu
Journal:  BMC Public Health       Date:  2013-07-17       Impact factor: 3.295

10.  Prevalence and Metabolic Factors of Hyperuricemia in an Elderly Agricultural and Fishing Population in Taiwan.

Authors:  Qian Yu; Hsi-Che Shen; Yi-Chun Hu; Yu-Fen Chen; Tao-Hsin Tung
Journal:  Arch Rheumatol       Date:  2017-04-13       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.